PWR
60
-2
FAST
46
-2
MCHP
42
-5
VRTX
56
-4
FOX
39
2
EQT
44
2
O
35
-2
VFC
57
4
THC
61
3
MRK
53
3
SIG
58
-2
AEE
61
-2
SO
64
-2
PX
52
-3
EXC
50
-4
GOOG
63
2
CHRW
48
8
IFF
60
-3
CA
36
-4
NTRS
47
-2
PWR
60
-2
FAST
46
-2
MCHP
42
-5
VRTX
56
-4
FOX
39
2
EQT
44
2
O
35
-2
VFC
57
4
THC
61
3
MRK
53
3
SIG
58
-2
AEE
61
-2
SO
64
-2
PX
52
-3
EXC
50
-4
GOOG
63
2
CHRW
48
8
IFF
60
-3
CA
36
-4
NTRS
47
-2
Financhill
Back

Madrigal Pharmaceuticals 10K Form

Sell
47

MDGL
Madrigal Pharmaceuticals

Last Price:
246.00
Seasonality Move:
23.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDGL News And Ratings

See the #1 stock for the next 7 days that we like better than MDGL

MDGL Financial Statistics

Sales & Book Value

Annual Sales: $150K
Cash Flow: $-140.08M
Price / Cash Flow: 0
Annual Sales: $39.50
Price / Book: 5.91

Profitability

EPS (TTM): -25.54000
Net Income (TTM): $-510.45M
Gross Margin: $0
Return on Equity: -113.99%
Return on Assets: -75.89%

Madrigal Pharmaceuticals Earnings Forecast

Key Madrigal Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for MDGL have been equal to 7,786.67% of Gross Profit Margin.
  • The Interest Expense is -3.40% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 8 years.

Madrigal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDGL
CUSIP: 558868
Website: madrigalpharma.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 8.72
Quick Ratio: 8.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDGL Technical Analysis vs Fundamental Analysis

Sell
47
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy or a Sell?